Rapid communication · 29 May 2025
Conference abstractPublished 2012
Angioinhibitory signaling mechanism(s) in choroidal endothelial cells by type IV collagen fragment
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Choroidal Neovascularization (CNV) leads to loss of vision in Age Related Macular Degeneration (AMD) that affects approximately 1 in 3 individuals over the age of 65. CNV of AMD is as common as cancer and one of the most prevalent causes of blindness in the United States of America. It has long been recognized that drugs targeting neovascularization may provide new and useful tools for the treatment of patients with CNV of AMD. The present available therapies in clinical trials come in the form of antibodies or antibody fragments that inhibit VEGF, which can only slow the progression of this eye disease. A renewed effort must therefore be made to identify efficient endogenous molecules that could be exploited as therapeutic agents. Thus, the present study shows the different angioinhibitory signalling mechanism(s) regulated by collagen type IV fragment α3(IV)NC1, whose mechanism of actions are yet to be deciphered.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Diabetes & Metabolism.
Rapid communication · 29 May 2025
Genetic and epigenetic markers for gdm risk
Short communication · 29 May 2025
Metabolic syndrome: Diet, timed eating, supplements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Sudhakar Akul-Yakkanti”